Contraceptive Devices are used to prevent the pregnancy by the use of drugs, medical devices, and surgical techniques. It also prevents the sexually Transmitted diseases (STDs). Contraceptive devices could be temporary or permanent and are available for both men and women. Permanent methods include sterilization for men (vasectomy) and sterilization for women (tubal occlusion or hysteroscopy). Temporary methods are hormonal (contraceptive transdermal patches, oral contraceptive pills, hormonal IUDs, vaginal rings, and vaginal implants) and non-hormonal (withdrawal methods, diaphragms, condoms, sponges, cervical caps, and non-hormonal IUDs. Condoms, diaphragms, sponges). The Contraceptive Devices market is expected to grow rapidly due to increase in awareness about the sexual and reproductive health.
How Big is The Global Contraceptive Devices Market?
The Global Contraceptive Devices Market is expected to be around US$ 22.50 Billion by 2028 at a CAGR of 7.5% in the given forecast period.
The major driving factors of Global Contraceptive Devices Market as follows:
The restraining factors of Global Contraceptive Devices Market as follows:
The Contraceptive Devices Market is segmented on the basis of its Product type, end use and geography. Based on product type it is segmented into Drugs (oral contraceptives, injectable and topical) and Devices (condom (male and female), diaphragms, sponges, vaginal rings, sub dermal implants and intrauterine devices (cooper IUD and Hormonal IUD). Further End User segmented into hospitals, clinics, home care and ambulatory surgical center (ASC). The Contraceptive Devices Market further segmented on geographic, which includes various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for contraceptive Devices and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Global Contraceptive Devices Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Report scope:
The scope of the report includes a detailed study of global and regional markets on Contraceptive Devices Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Cooper Surgical, Inc. (U.S.), Pfizer, Inc. (U.S.), Actavis, Inc. (U.S.), Teva Pharmaceutical Industries Limited (Israel), Bayer AG (Germany), The Female Health Company (U.S.), Merck & Co., Inc. (U.S.), Mayer Laboratories, Inc. (U.S.), Church & Dwight, Co., Inc. (U.S.), Medisafe Distribution Inc. (Canada), and others. Company profile such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Contraceptive Devices Market has been segmented as below:
By Product Analysis:
By End User Analysis:
By Regional Analysis:
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global Contraceptive Devices Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Contraceptive Devices Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
1 INTRODUCTION
1.1 KEY TAKE AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES
2. RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE CONTRACEPTIVE DEVICES MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6. PORTER’S FIVE FORCES MATRIX
2.3. GLOBAL CONTRACEPTIVE DEVICES MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.2.1. INCREASED RATE OF UNPLANNED PREGNANCIES
3.2.2. RISING NUMBER OF INITIATIVES UNDERTAKEN BY THE PRIVATE FIRMS
3.2.3. FAVOURABLE INSURANCE FOR IUCD’S
3.2.4. GROWING AWARENESS OF CONTRACEPTIVE
3.2.5. GROWING FUNDS AND GRANTS FOR IUCD PRODUCTS
3.2.6. TECHNOLOGICAL ADVANCEMENTS
3.2. RESTRAINTS
3.2.1. HIGH COST OF TREATMENT
3.2.2. THREAT OF CAUSING PELVIC INFLAMMOTORY DISEASE (PID)
3.2.3. THREAT CAUSING EPICTAPIC PREGNANCY
3.2.4. CHANGES IN GOVERNMENT REGULATIONS
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. GLOBAL CONTRACEPTIVE DEVICES MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. HORMONAL IUCD (2013 – 2024)
6.2.1. MARKET VALUE (USD MILLION)
6.2.2. MARKET VOLUME (UNITS SOLD)
6.3. COPPER IUCD (2013 – 2024)
6.3.1. MARKET VALUE (USD MILLION)
6.3.2. MARKET VOLUME (UNITS SOLD)
7. GLOBAL CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY
7.1. COUNTRYWISE CONTRACEPTIVE DEVICES MARKET,
7.1.1. NORTH AMERICA
7.1.1.1. U.S.
7.1.1.2. CANADA
7.1.1.3. MEXICO
7.1.2. EUROPE
7.1.2.1. GERMANY
7.1.2.2. FRANCE
7.1.2.3. U.K.
7.1.2.4. ITALY
7.1.2.5. SPAIN
7.1.2.6. RUSSIA
7.1.2.7. TURKEY
7.1.2.8. BELGIUM
7.1.2.9. NETHERLANDS
7.1.2.10. SWITZERLAND
7.1.2.11. REST OF EUROPE
7.1.3. ASIA-PACIFIC (APAC)
7.1.3.1. JAPAN
7.1.3.2. CHINA
7.1.3.3. SOUTH KOREA
7.1.3.4. INDIA
7.1.3.5. AUSTRALIA
7.1.3.6. SINGAPORE
7.1.3.7. THAILAND
7.1.3.8. MALAYSIA
7.1.3.9. INDONESIA
7.1.3.10. PHILIPPINES
7.1.3.11. REST OF APAC
7.1.4. LATIN AMERICA
7.1.4.1. BRAZIL
7.1.4.2. COLOMBIA
7.1.4.3. ARGENTINA
7.1.4.4. CHILE
7.1.4.5. ECUADOR
7.1.4.6. URUGUAY
7.1.4.7. PARAGUAY
7.1.4.8. PERU
7.1.4.9. BOLIVIA
7.1.4.10. REST OF LATIN AMERICA
7.1.5. MIDDLE EAST AND AFRICA
7.1.5.1. EGYPT
7.1.5.2. SAUDI ARABIA
7.1.5.3. REST OF SOUTH AMERICA
7.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
8. GLOBAL CONTRACEPTIVE DEVICES MARKET: COMPETITIVE LANDSCAPE
8.1. GLOBAL IUCD MARKET: COMPANY SHARE ANALYSIS
8.2. U.S.IUCD MARKET: COMPANY SHARE ANALYSIS
8.3. EUROPE IUCD MARKET: COMPANY SHARE ANALYSIS
8.4. APAC IUCD MARKET: COMPANY SHARE ANALYSIS
8.5. SOUTH AMERICAIUCD MARKET: COMPANY SHARE ANALYSIS
8.6. MIDDLE EAST AND AFRICA IUCD MARKET: COMPANY SHARE ANALYSIS
8.7. MERGERS & ACQUISITIONS
8.8. NEW PRODUCT DEVELOPMENT & APPROVALS
8.9. EXPANSIONS
8.10. REGULATORY CHANGES
8.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
9. GLOBAL CONTRACEPTIVE DEVICES MARKET, COMPANY PROFILES
9.1. BAYER HEALTHCARE AG
9.1.1 OVERVIEW
9.1.2 SWOT ANALYSIS
9.1.3 PRODUCT PORTFOLIO
9.1.4 REVENUE ANALYSIS
9.1.5 ANALYSTS VIEW
9.2. DKT INTERNATIONAL
9.2.1 OVERVIEW
9.2.2 SWOT ANALYSIS
9.2.3 PRODUCT PORTFOLIO
9.2.4 REVENUE ANALYSIS
9.2.5 ANALYSTS VIEW
9.3. TEVA PHARMACEUTICALS INDUSTRIES, LTD
9.3.1 OVERVIEW
9.3.2 SWOT ANALYSIS
9.3.3 PRODUCT PORTFOLIO
9.3.4 REVENUE ANALYSIS
9.3.5 ANALYST VIEW
9.4. ALLERGEN, PLC
9.4.1 OVERVIEW
9.4.2 SWOT ANALYSIS
9.4.3 PRODUCT PORTFOLIO
9.4.4 REVENUE ANALYSIS
9.4.5 ANALYSTS VIEW
9.5. SMB CORPORATION
9.5.1 OVERVIEW
9.5.2 SWOT ANALYSIS
9.5.3 PRODUCT PORTFOLIO
9.5.4 REVENUE ANALYSIS
9.5.5 ANALYSTS VIEW
9.6. ACTAVIS PLC.
9.6.1 OVERVIEW
9.6.2 SWOT ANALYSIS
9.6.3 PRODUCT PORTFOLIO
9.6.4 REVENUE ANALYSIS
9.6.5 ANALYSTS VIEW
9.7 OCON MEDICAL LTD.
9.7.1 OVERVIEW
9.7.2 SWOT ANALYSIS
9.7.3 PRODUCT PORTFOLIO
9.7.4 REVENUE ANALYSIS
9.7.5 ANALYSTS VIEW
9.8 MONALISA NV
9.8.1 OVERVIEW
9.8.2 SWOT ANALYSIS
9.8.3 PRODUCT PORTFOLIO
9.8.4 REVENUE ANALYSIS
9.8.5 ANALYSTS VIEW
9.9 MEDISAFE DISTRIBUTION, INC.
9.9.1 OVERVIEW
9.9.2 SWOT ANALYSIS
9.9.3 PRODUCT PORTFOLIO
9.9.4 REVENUE ANALYSIS
9.9.5 ANALYSTS VIEW
9.10 MERIL LIFE SCIENCES PVT. LTD.
9.10.1 OVERVIEW
9.10.2 SWOT ANALYSIS
9.10.3 PRODUCT PORTFOLIO
9.10.4 REVENUE ANALYSIS
9.10.5 ANALYSTS VIEW
The Global Contraceptive Devices Market has been segmented as below:
By Product Analysis:
By End User Analysis:
By Regional Analysis:
SUBSCRIBE TO OUR NEWSLETTERS
